-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A national procurement renewal bid, the biggest move was the 13-province alliance led by Guangdong, which was the first and third batches, with a total of 45 varieties
.
This time, Henan took the lead, and it was still 13 provinces, but it became the second and fourth batches of national mining, with 33 varieties
.
From 1-3 to 2-4, this seems to be an intentional or unintentional rotation of the "leading big brother" of the Renewal League
.
It is worth noting that in addition to leading the alliance of 13 provinces this time, Henan simply collected the first batch of 18 varieties of cephalexin in the province and the previous one-time organization of cephalexin in the Guangdong Alliance to organize medical institutions to report a total of 52 varieties (33+18+1 ) are listed at the end of the text
.
Guangdong Alliance, a total of 233 companies signed up, involving 690 varieties, 314 companies were selected, and 132 companies were selected, with a selection rate of 70.
45%; the average price dropped by 27.
5% on the basis of the previous price selection in the country
.
This time, Henan requires medical institutions to report the demand for the next year (July 1, 2022 to June 30, 2023), and the reporting time is April 18, 2022 to April 26
.
The volume of reports will largely determine the success or failure of procurement with volume, which is valued by the Medical Insurance Bureau and concerned by enterprises
.
The amount reported, whether it is consistent with the actual situation, and how much there is a gap will affect the participation of the company and the adjustment of the price reduction rate
.
Therefore, the Henan Provincial Medical Insurance Bureau requires: All medical institutions should adhere to seeking truth from facts, and reasonably fill in the pre-purchased volume of drugs based on the agreed procurement volume of the unit and the actual use of the previous procurement cycle
.
In principle, the pre-purchased amount shall not be less than the actual consumption of the unit in the previous procurement cycle.
If the increase or decrease exceeds 20%, an explanation shall be made.
For medical institutions that deliberately under-report or do not report the amount, the medical insurance departments at all levels shall issue a letter.
Ask for an appointment
.
This report amount seems to be learned from the sixth batch of national centralized procurement (special insulin)? Previously, Henan organized the first batch of provincial-level and 14-province centralized procurement alliances (14 provinces of Henan, Shanxi, Mongolia, Guangdong, Guiyu, Yunnan, Shaanxi, Qingning and New Corps)
.
27 varieties were selected in the first batch at the provincial level.
The results of the selection will be implemented before March 1, 2021.
After the procurement period expires, the contract will be renewed.
The implementation period is from July 1, 2022 to June 30, 2023
.
Previously (February 2022), Henan reported the procurement of the provincial standard varieties: 6 standard varieties, and the purchase amount exceeded 200 million in 4 and a half months
.
The hospitals are required to explain the reasons in the medical records.
If the reasons are not explained, the medical insurance fund will not pay
.
During the same period, the provincial centralized procurement of similar alternative varieties (non-medical insurance) totaled 190 million yuan
.
The 14-province centralized procurement alliance led by Henan, according to the procurement rules, is divided into AB groups, and 3 or more companies are comprehensively evaluated according to the weight of price and technology of 6:4
.
If the quotation of the enterprise is not higher than 0.
1 yuan and is not higher than the lowest price of the drug at the national provincial level (the winning bid) of the enterprise, it is not limited by the amount to be selected, and it can directly obtain the qualification to be selected
.
In the end, 38 drugs were selected by the 14-province alliance, and 29 varieties of group B were selected, with the highest drop of 89.
64%
.
At that time, Henan made it clear that 9,507 medical insurance designated retail chain pharmacies were included in the scope of provincial drug collection (pilot), and 275 retail pharmacy chain enterprises began to lead the 14-province alliance collection and reporting work in Henan
.
At the same time, it is stipulated that the centralized procurement of drugs shall not be placed in non-centralized designated retail pharmacies; if they are distributed privately, once found, the retail enterprise and all its stores will be disqualified from participating in the province's centralized drug procurement
.
This provision seems to prevent "smuggling" from happening
.
This pair of retail pharmacy reporting and management regulations will accompany the 13-province renewal centralized procurement alliance led by Henan
.
.
This time, Henan took the lead, and it was still 13 provinces, but it became the second and fourth batches of national mining, with 33 varieties
.
From 1-3 to 2-4, this seems to be an intentional or unintentional rotation of the "leading big brother" of the Renewal League
.
It is worth noting that in addition to leading the alliance of 13 provinces this time, Henan simply collected the first batch of 18 varieties of cephalexin in the province and the previous one-time organization of cephalexin in the Guangdong Alliance to organize medical institutions to report a total of 52 varieties (33+18+1 ) are listed at the end of the text
.
Guangdong Alliance, a total of 233 companies signed up, involving 690 varieties, 314 companies were selected, and 132 companies were selected, with a selection rate of 70.
45%; the average price dropped by 27.
5% on the basis of the previous price selection in the country
.
This time, Henan requires medical institutions to report the demand for the next year (July 1, 2022 to June 30, 2023), and the reporting time is April 18, 2022 to April 26
.
The volume of reports will largely determine the success or failure of procurement with volume, which is valued by the Medical Insurance Bureau and concerned by enterprises
.
The amount reported, whether it is consistent with the actual situation, and how much there is a gap will affect the participation of the company and the adjustment of the price reduction rate
.
Therefore, the Henan Provincial Medical Insurance Bureau requires: All medical institutions should adhere to seeking truth from facts, and reasonably fill in the pre-purchased volume of drugs based on the agreed procurement volume of the unit and the actual use of the previous procurement cycle
.
In principle, the pre-purchased amount shall not be less than the actual consumption of the unit in the previous procurement cycle.
If the increase or decrease exceeds 20%, an explanation shall be made.
For medical institutions that deliberately under-report or do not report the amount, the medical insurance departments at all levels shall issue a letter.
Ask for an appointment
.
This report amount seems to be learned from the sixth batch of national centralized procurement (special insulin)? Previously, Henan organized the first batch of provincial-level and 14-province centralized procurement alliances (14 provinces of Henan, Shanxi, Mongolia, Guangdong, Guiyu, Yunnan, Shaanxi, Qingning and New Corps)
.
27 varieties were selected in the first batch at the provincial level.
The results of the selection will be implemented before March 1, 2021.
After the procurement period expires, the contract will be renewed.
The implementation period is from July 1, 2022 to June 30, 2023
.
Previously (February 2022), Henan reported the procurement of the provincial standard varieties: 6 standard varieties, and the purchase amount exceeded 200 million in 4 and a half months
.
The hospitals are required to explain the reasons in the medical records.
If the reasons are not explained, the medical insurance fund will not pay
.
During the same period, the provincial centralized procurement of similar alternative varieties (non-medical insurance) totaled 190 million yuan
.
The 14-province centralized procurement alliance led by Henan, according to the procurement rules, is divided into AB groups, and 3 or more companies are comprehensively evaluated according to the weight of price and technology of 6:4
.
If the quotation of the enterprise is not higher than 0.
1 yuan and is not higher than the lowest price of the drug at the national provincial level (the winning bid) of the enterprise, it is not limited by the amount to be selected, and it can directly obtain the qualification to be selected
.
In the end, 38 drugs were selected by the 14-province alliance, and 29 varieties of group B were selected, with the highest drop of 89.
64%
.
At that time, Henan made it clear that 9,507 medical insurance designated retail chain pharmacies were included in the scope of provincial drug collection (pilot), and 275 retail pharmacy chain enterprises began to lead the 14-province alliance collection and reporting work in Henan
.
At the same time, it is stipulated that the centralized procurement of drugs shall not be placed in non-centralized designated retail pharmacies; if they are distributed privately, once found, the retail enterprise and all its stores will be disqualified from participating in the province's centralized drug procurement
.
This provision seems to prevent "smuggling" from happening
.
This pair of retail pharmacy reporting and management regulations will accompany the 13-province renewal centralized procurement alliance led by Henan
.
